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T cell migration is crucial for an effective adaptive immune response to invading pathogens.
Naive and memory T cells encounter pathogen antigens, become activated, and differen-
tiate into effector cells in secondary lymphoid tissues, and then migrate to the site(s)
of infection where they exert effector activities that control and eliminate pathogens. To
achieve activation, efficient effector function, and good memory formation,T cells must traf-
fic between lymphoid and non-lymphoid tissues within the body. This complex process is
facilitated by chemokine receptors, selectins, CD44, and integrins that mediate the interac-
tions ofT cells with the environment.The expression patterns of these migration receptors
(MR) dictate the tissues into which the effectorT cells migrate and enable them to occupy
specific niches within the tissue. While MR have been considered primarily to facilitate
cell movement, we highlight how the heterogeneity of signaling through these receptors
influences the function and fate of T cells in situ. We explore what drives MR expression
heterogeneity, how this affects migration, and how this impactsT cell effector function and
memory formation.
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INTRODUCTION
In this review, we focus on T cell heterogeneity defined as the
variation in the expression of migration receptors (MR), includ-
ing chemokine receptors (CCRs), selectins, CD44, and integrins.
The heterogeneity of effector T cells is evident during clonal
expansion, differentiation, functional development, and transi-
tion to memory and is influenced by interactions with dendritic
cells (DC), the tissue environment, and the inflammatory status.
MR expression heterogeneity not only governs T cell migration
to specific niches in the lymphoid tissues or in non-lymphoid
sites of infection and inflammation, but also allows for contex-
tual communication through engagement of the microenviron-
ment at these sites to facilitate T cell differentiation and effector
function.
SETTING THE SCENE: MOTILITY ENABLES THE INITIATION
OF THE T CELL RESPONSE
For pathogens that enter and infect sites that interface with the
external environment, such as the lung, skin, and intestinal tract,
a complex interplay of innate and adaptive immune responses is
required to achieve pathogen control and/or clearance. A func-
tional T cell response is a crucial component of effective immu-
nity to infection with pathogens and is influenced by a multi-
tude of factors that include the microbe-specific mechanisms of
host engagement, the site(s) of entry, and the virulence of the
pathogen. Migration of T cells is crucial for an effective effec-
tor response to occur. For many intracellular pathogens, control
and/or clearance depends upon the effector activities of CD8+
and CD4+ T cells that are programed to mediate type I responses
characterized by cytolytic activity and production of cytokines,
such as interferon (IFN)-γ and tumor necrosis factor (TNF)-α.
These responses are initiated primarily by antigen-presenting DC
that have migrated from the site of infection to the secondary lym-
phoid organs (SLO). In lymph nodes (LN), DC compartmentalize
into the T cell zone along fibroblastic reticular cells that express
the CCR7 ligands, CCL19 and CCL21 (1, 2). In systemic infec-
tions, responses are also initiated in the spleen, where DC enter
from the blood into the marginal zone of the red pulp, and from
there migrate into the T cell zone of the white pulp in response
to CCR7 ligands. DC become functional as antigen-presenting
cells (APC) by upregulating MHC molecules and co-stimulatory
molecules in response to innate signals that include pathogen-
induced toll-like receptors and type I IFN, as well as by signaling
via MR in response to migration (3). Many pathogen-specific
aspects dictate and influence the innate response (4), which in
turn impacts the extent of effector development in the adaptive
response through effects on macrophages, DC, and other innate
immune cells.
Highly motile naïve T cells that themselves are continuously
recirculating interact with DC after entry into SLO. T cell migra-
tion from the blood into different tissues is regulated by a general
cascade of events that is initiated by engagement of endothelial
cells. This interaction consists of rolling and tethering, followed by
firm adhesion, spreading/crawling, and finally extravasation (5).
For naïve T cells, it is well-established that L-selectin (CD62L),
CCR7, and LFA (CD18, β2) are the key molecules that regulate
entry into LNs, which occurs through high endothelial venules
that present their respective ligands, PNAd, CCL21, and ICAM-1.
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Within the LN, naïve T cells undergo cytoskeletal rearrangements
that support motility, which in combination with CCR signal-
ing facilitates directional motility toward DC (6). Naïve antigen-
specific T cells engage antigen-bearing DC in a progression of serial
encounters that result in the upregulation of activation markers
such as CD69, CD25, and CD44. To ensure maximal activation
and early retention in the LN, expression of the sphingosine-1-
phosphate receptor 1 (S1P1) is initially reduced thereby lowering
the ability of the T cell to be responsive to blood S1P levels
[reviewed in Ref. (7)]. When T cells engage DC, their motility
is greatly reduced and extended contacts between T cells and
DC facilitate optimal activation and differentiation. During this
process, MR expression profiles change dramatically. The impact
of MR heterogeneity on T cell migrational capacity and effector
function will be discussed in more detail below.
INDUCTION OF MIGRATORY HETEROGENEITY DURING
EFFECTOR T CELL DEVELOPMENT
MR expression and ligation have important roles in T cell activa-
tion processes and thereby control effector T cell development
in lymphoid tissues and non-lymphoid sites of infection and
inflammation. At early stages in the development of effectors, MR
heterogeneity is introduced by the differences in activation states
of responding T cells that are largely determined by the degree
of access to highly stimulatory APC. Here, we will explore the
contribution of T cell receptor (TCR) affinity, the level of co-
stimulation, and the cytokine milieu to MR expression and how
they can influence MR heterogeneity during priming (Figure 1).
TCR SIGNALING INDUCES MR REDISTRIBUTION AND DE
NOVO MR EXPRESSION
Effective T cell activation depends on a dynamic interplay between
TCR and peptide-MHC binding kinetics and the epitope density
on the DC. MR play a direct role in the formation of the immuno-
logical synapse when engaging APC through actin rearrangement
[reviewed in Ref. (8)]. Cytoskeletal rearrangements that involve
the actin-binding ezrin, radixin, and moesin (ERM) proteins are
necessary for T cell activation and IL-2 production (9, 10). To
achieve TCR signaling complex polarization, MR that include
CD44, CD62L, P-selectin glycoprotein (PSGL)-1, and ICAMs 1–
3, become excluded from the central immunological synapse
where the TCR and associated signaling molecules coalesce to
form the central supramolecular activation cluster (cSMAC). The
aforementioned MR become cross-linked to the actin cytoskele-
ton at the back of the cell, whereas the integrin LFA-1 forms a
ring surrounding the cSMAC that supports prolonged T cell-DC
FIGURE 1 | Induction of migratory heterogeneity during priming. MR
phenotype is impacted by TCR engagement, the level of co-stimulation, and
the cytokine milieu (left ). MR play a direct role in the formation of the
immunological synapse, but TCR signaling subsequently impacts MR
expression [panel 1, adapted from Ref. (8)]. Cytoskeletal rearrangements
that involve the actin-binding ezrin (ezr), radixin, and moesin (mo) proteins
are necessary for TCR signaling complex polarization. The integrin LFA-1
forms a ring surrounding the cSMAC that supports prolonged T cell-DC
engagement, while other MR become excluded from the cSMAC. This
process is possibly due to differential polarization of ezrin and moesin.
Co-stimulatory signaling through molecules also contributes to the
migratory heterogeneity of T cells (panel 2). For example, CD28 controls
migration through upregulation of OX40, which is instrumental for CXCR5
expression and T cell localization to germinal centers (GC). In addition
CD28/TCR signaling activates the PI3K/AKT pathway, which inhibits Foxo1
leading to decreased KLF2 expression. Differential co-stimulation can
impact the levels of CD62L, CCR7, and S1P1 and thereby regulate the
egress of T cells into the circulation. Cytokines released by DC promote
specific transcriptional profiles that introduce further MR heterogeneity
(panel 3). DC-derived IL-12 induces expression of the transcription factor
T-bet and determines a CD4+Th1 or CD8+ effector transcriptional program
that results in part in the expression of CXCR3 and PSGL-1, which contribute
to homing to peripheral sites. Alternatively, induction of the Tfh-associated
transcription factor Bcl6 by IL-6 and IL-21 results in the downregulation of
PSGL-1 and increased expression of CXCR5, which allows these cells to
migrate from the T cell zones in the paracortex into GC.
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engagement (11). Although little is known regarding the mecha-
nisms by which T cells disengage from APC, once this occurs, T
cells can interact with other cells via MR. For example, a recent
study demonstrates that reciprocal ICAM-LFA interactions facili-
tate antigen-independent T cell–T cell synapses,which are required
for the optimal generation of CD8+ effector T cell responses (12).
These findings underscore that proper distribution and coordi-
nated interplay of molecules in the TCR complex and MR are
critical for full T cell activation.
The strength of TCR signaling represents a key checkpoint in
the development of heterogeneous effector T cells. Strong stimula-
tory conditions lead to modulation of MR including upregulation
of various integrins, CD44, and PSGL-1, with downregulation of
CD62L and CCR7, a phenotype associated with the most highly
functional effectors. This can, to some extent, be achieved by acti-
vating T cells with high affinity TCRs that can engage greater or
distinct downstream signaling compared to low affinity TCRs (13,
14), and can result in proliferation versus cytokine production
(13). However, for both CD4+ and CD8+ T cells, even individual
naïve cell clones can give rise to a whole spectrum of heterogeneous
effector phenotypes that can be influenced by antigen-dose and the
duration of peptide-MHC binding for CD4+ T cells (15–17).
CO-STIMULATION DURING PRIMING IMPACTS MR
HETEROGENEITY
Another major contributor to T cell activation and modulation
of MR expression is the availability of co-stimulatory signaling
through molecules such as CD28 that are not only essential for T
cell proliferation, differentiation, and survival, but also impact T
cell migration (Figure 1, panel 2). The amount of co-stimulation
received and the individual co-stimulatory receptor(s) involved
in T cell activation can also contribute to the migratory hetero-
geneity of T cells responding to a pathogen. For example, while
CD28 and CTLA4 engagement both increaseβ1 integrin-mediated
adhesion (18, 19), ligation of these co-stimulatory markers has
markedly different effects on T cell migration. Engagement of
CD28 enhances the migrational capacity of T cells into inflamed
tissue whereas ligation of CTLA4 inhibits T cell recruitment (20).
However, the underlying mechanisms of these opposing effects
are unknown. CD28 controls migration through upregulation of
OX40, which is instrumental for CXCR5 expression and T cell
localization to germinal centers (21). Co-stimulation by CD28 in
combination with strong TCR signaling activates the PI3K/AKT
pathway, a key regulator of glucose metabolism, which together
with the mammalian target of rapamycin (mTOR) orchestrates
the energy demands necessary for effector development (22). The
PI3K/AKT and mTOR pathways not only regulate the necessary
metabolic changes to the T cell, but also regulate their migra-
tory capacity. Specifically, mTOR and Akt activation inhibits the
Foxo family of transcription factors leading to decreased expres-
sion of kruppel-like factor 2 (KLF2), which in turn leads to the
reduced expression of CD62L, the IL-7 receptor, and CCR7 (23–
26). Importantly for the ability of cells to leave the LN, KLF2 also
regulates the expression of S1P1 promoting the egress of T cells
into the circulation (27).
CCR7 and CD62L expression may also be impacted by signal-
ing via the co-stimulatory molecule ICOS, which is a member of
the CD28-superfamily and expressed on activated T cells. Ligation
of ICOS was demonstrated to down-regulate CCR7 and CD62L
after activation, leading to more efficient migration of CD4+ T
cells into the lungs and a reduced return to the LN (28).
Whether other co-stimulatory pathways link migratory capac-
ity and T cell activation has not yet been defined, but activated T
cells express high levels of multiple MR, and engagement of MR
themselves can provide co-stimulation. Early participation of T
cells in a response, when antigen levels and co-stimulatory sig-
nals are high, leads to loss of CD62L and increased expression of
CD44, PSGL-1, S1P1, and the integrins LFA-1 and/or α4β1 (VLA-
4) as well as other integrins that engage the extracellular matrix
(ECM) (29). LFA-1 contributes to T cell responses by enhanc-
ing TCR signaling, production of IL-2, and proliferation, but also
modulates T cell polarization and motility (11). α4β1 can also con-
tribute to Th1 development by acting as a co-stimulatory molecule
(30). In addition, pro-inflammatory cytokines can rapidly upreg-
ulate CD44 and its ability to bind its ligand, the ECM component
hyaluronic acid (HA) (31). DC can synthesize and bind HA and
during naïve T cell-DC interactions, ligation of CD44 by HA can
enhance T cell cytokine production and proliferation by T cells
that have received signals through the TCR (32). Similarly, ligand
binding capacity is induced on PSGL-1 in response to T cell acti-
vation. In our own work, we find that CD4+ Th1 effector cells are
heterogeneous with respect to expression of functional PSGL-1.
Specifically, those cells with the highest levels of functional PSGL-
1 are the most proliferative effectors with the greatest capacity for
effector cytokine secretion and for cytotoxic activity (Bradley and
Swain, unpublished observations).
DC-DERIVED CYTOKINES DRIVE DISTINCT MR EXPRESSION
PROFILES IN T CELL SUBSETS
DC further influence T cell heterogeneity by virtue of the cytokines
they secrete (3). As the immune response progresses, exposure of
activated CD4+ T cells to polarizing cytokines leads to the devel-
opment of subsets variously defined by function and transcription
factor expression. These include the well-defined Th1, Th2, Th17,
Tfh, and Treg subsets and the less understood Th9 and Th22 sub-
sets, as well as CD4+ cells with cytotoxic activity, ThCTL (33).
Cytokines released by DC work in part by inducing particular
transcriptional profiles in T cells that promote expression of effec-
tor cytokines, but they also induce the expression of MR that allow
for microanatomical localization (Figure 1, panel 2). For example,
T cell activation is associated with the expression of the transcrip-
tion factors Blimp-1 as well as T-bet. T-bet expression is sustained
by DC-derived IL-12 and determines a CD4+ Th1 and CD8+
transcriptional program, which allows effector T cells to produce
IFN-γ (33). T-bet induction is accompanied by the expression
of CXCR3 (34) that binds the chemokines CXCL9, CXCL10,
and CXCL11, which are frequently associated with inflammation.
Asymmetric division can be associated with differential partition-
ing of T-bet (35, 36) and might also contribute to effector cell
heterogeneity. This concept has been predominantly studied in
terms of the generation of effector T cells that give rise to subsets
memory cells that differentially express CD62L/CCR7 (see Role
of Location and MR Signaling on the Effector to Memory T Cell
Transition). Tfh cells develop concurrently with Th1 and CD8+
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effector cells, regulated by induction of the transcription factor
Bcl6 (with loss of Blimp-1) (37), which results in the downregu-
lation of PSGL-1 (38), loss of CCR7, and increased expression of
CTLA4 and CXCR5. The expression of CXCR5 results in increased
responsiveness to CXCL13 and allows Tfh cells to migrate into B
cell follicles in SLO (39).
Thus, changes in MR expression define unique phenotypes that
can play critical roles in the migration and retention of effector
cells. The combined outcome of TCR engagement of MHC in the
context of peptide, signaling via co-stimulatory molecules, and
access to polarizing cytokines determines in part the heterogene-
ity in MR expression profiles on T cell, which has a significant
effect on their ability to exert their effector function.
DISTINCT MR EXPRESSION PROFILES DETERMINE
TISSUE-SPECIFIC MIGRATION AND EFFECTOR FUNCTION
In general, effector T cells express a variety of MR that may be
used alternatively or in combinations for migration and reten-
tion at sites of inflammation, which has led to the concept that
expression of distinct MR combinations results in tissue-specific
migration (Figure 2). For example, there is considerable evidence
that a specialized program develops in T cells that are primed
in gut-associated lymphoid tissues (mesenteric LN and Peyer’s
patches) that directs migration into the gut mucosa. Effector T
cells in these sites preferentially express functional PSGL-1, α4β7,
and CCR9, which support migration via P-selectin, MAdCAM-
1, and CCL25, respectively, through the post capillary venules of
the small intestine to enter the lamina propria and intraepithe-
lial compartment (40, 41). CD103 (integrin αE)-expressing DC
impart the intestinal homing signature on T cells during priming,
although CD103-positive and -negative DC populations can both
prime T cells (42, 43). The induction of α4β7 and CCR9 is driven
by retinoic acid, which is specifically synthesized by gut-associated
CD103-positive DC, but not by CD103-negative or extra-intestinal
DC (44). This capacity of intestinal CD103-positive DC to produce
retinoic acid is acquired via toll-like receptor signaling,presumably
in response to interactions with the microbiota (45). In addi-
tion to CD103-positive DC, the stroma of the mesenteric LN
also expresses high levels of retinoic acid-producing enzymes and
may have a considerable effect on the intestinal homing signature
FIGURE 2 | Induction of tissue-specific MR profile. Expression of distinct
MR combinations results in tissue-specific migration. T cells that are primed
in gut-associated lymphoid tissues preferentially express functional PSGL-1,
α4β7, and CCR9, which support migration through the post capillary venules of
the small intestine to enter the lamina propria and intraepithelial compartment
(panel 1). CD103-expressing DC impart the intestinal homing signature on T
cells during priming by expression of retinoic acid (RA) in response to
microbiota-driven toll-like receptor (TLR) signaling. A different program of MR
usage is induced during priming of naïve T cells in skin-draining LN (panel 2). T
cells in the skin express the cutaneous lymphocyte antigen (CLA), an
inducible carbohydrate modification of PSGL-1, CCR4, CCR8, CCR10, α4β1,
and LFA-1, which mitigates their migration into the skin. Analogous to
intestinal imprinting, CCR10, but not CCR4, expression is regulated by
skin-draining DCs that synthesize the vitamin D3 metabolite, 1,25(OH)2D3.
1,25(OH)2D3 suppresses α4β7 and CCR9 expression and RA inhibits CCR4 and
CCR10 expression. In addition, CCR8 expression is imprinted by epidermal
keratinocytes, although the skin-specific factors that induce CCR8 remain
unknown. Evidence for imprinting of T cells in the lung is limited, but recent
evidence suggests that lung DC-activated T cell migrate more efficiently into
the lung, which was attributed to CCR4, although other MR are likely to
contribute (panel 3). Many lymphocytes in the lung express high levels of
α4β1, α1β1, and LFA-1 and CD8+T cells primed in the mediastinal LN are
enriched for CCR5 and CXCR3 expression, suggesting a pulmonary profile
driven by distinct molecular mechanisms.
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of T cells (46). T cell migration to the gut epithelium leads to
TGF-β-dependent induction of αEβ7 on the T cells, which con-
tributes to the retention of both CD4+ and CD8+ effectors
by engagement of epithelial cell-expressed E-cadherin. Once an
effector response subsides, residual CD8+ T cells can remain in
the epithelial compartment as memory cells by this mechanism.
CD4+ T cells are primarily maintained in the lamina propria,
where they may require the continued local exposure to antigen
for persistence.
A different program of MR usage is induced during priming
of naïve T cells in skin-draining LN under inflammatory con-
ditions. Both migrating Langerhans cells and conventional DC
can present antigens to naïve T cells (47). Upon activation, these
T cells express the cutaneous lymphocyte antigen, an inducible
carbohydrate modification of PSGL-1 that preferentially binds to
E-selectin on the endothelium of inflamed skin (48, 49). CD43
and CD44 expressed by T cells can also act to engage E-selectin.
Although many chemokines can participate in migration of effec-
tor T cells to the skin depending on the characteristics of the
infection or inflammation (50), the capacity for recruitment of
effector T cells to the skin is primarily associated with expres-
sion of CCR8 and CCR10. While skin T cells express high levels
of CCR4 and its ligands CCL17 and CCL22 are produced by
epidermal keratinocytes and dermal fibroblasts, skin DC have
not been shown to imprint CCR4 expression, which suggests
that this MR is not exclusively a skin-homing molecule. Con-
versely, CCR8 expression on T cells is imprinted by epidermal
keratinocytes, although the skin-specific factors that induce CCR8
remain unknown (51). CCR10 is also acquired by effector CD8+T
cells that migrate to skin in response to the epidermal chemokine
CCL27. Analogous to intestinal imprinting, CCR10 expression
is regulated by skin-draining DCs that synthesize the vitamin
D3 metabolite, 1,25(OH)2D3 (52). While1,25(OH)2D3 suppresses
α4β7 and CCR9 expression, it is not sufficient to induce a bona fide
skin-homing program (i.e., other skin-homing receptors are not
induced). Interestingly, retinoic acid inhibits the generation of T
cells expressing these skin-homing receptors. The integrins LFA-1
and α4β1 can both mediate transmigration from the blood into the
skin through engagement of their respective ligands, ICAM-1 and
VCAM-1 (53). Expression of the αEβ7 integrin is also highly asso-
ciated with skin-homing effector T cells and is thought to account
for retention of effector cells that can make a transition to memory
in situ [(54), see below].
While specific MR phenotypes that allow directed migration
to the intestinal mucosa or skin have been identified, evidence
for distinct MR expression patterns for the respiratory system has
been lacking. In a recent paper, CD4+ and CD8+ T cells that were
activated specifically by lung DC were shown to home more effi-
ciently into the lung in response to inhaled antigen (55). CCR4
contributed to the lung-homing advantage of lung DC-activated
CD4+ T cells and to reduced morbidity in vivo in response to
influenza virus infection. However, this was a partial effect and
it is likely that other MR are induced by lung DC. For example,
we demonstrated that numerous genes involved in cell migra-
tion and motility are differentially expressed between lymphocytes
responding in the SLO versus the lung (56) and many lymphocytes
in the lung express high levels of α4β1, α1β1 (CD49a, VLA-1), and
LFA-1 (57–61). In addition, CD8+ T cells primed in the lung-
draining mediastinal LN by DC are enriched for CCR5 and CXCR3
expression compared to T cells primed in other sites (62) and these
receptors regulate T cell effector responses and their contraction
after infections with influenza viruses or Mycobacterium tubercu-
losis (Mtb) (63). Thus, it is tempting to speculate that some MR
contribute to a specific pulmonary profile driven by distinct mol-
ecular mechanisms (see also Role of Location and MR Signaling
on the Effector to Memory T Cell Transition).
A critical factor that can also impact T cell migration to partic-
ular sites is the changes to the site mediated by the pathogen and
the inflammation initiated by the pathogen. Inflammation can
alter the functional activity of the stromal cells thereby impact-
ing recruitment from the circulation. After influenza virus infec-
tion, the ThCTL subset and ThCTL-associated genes are observed
almost exclusively in the lung (56, 64, 65) suggesting a role for
virus-specific inflammation in coordinating migration and func-
tion. For effective immunity to influenza virus, activated CD8+ T
cells need to interact with pulmonary DC in an antigen-specific
manner at the site of inflammation and while the impact on
MR phenotype was not studied, this interaction could intro-
duce additional heterogeneity (66). Following infection with Mtb,
the infected site becomes dominated by macrophages before the
arrival of T cells, thereby creating an environment very differ-
ent from the normal lung (67). Indeed as disease, develops T cell
migration into the lung and within the inflamed site appears to
be regulated by the development of B cell follicles and the expres-
sion of CXCL13 (68, 69). We have demonstrated that within the
chronically inflamed Mtb-infected tissue, activated effector T cells
express high levels of α4β1 and that this is regulated by the pres-
ence of nitric oxide (70). This brings to prominence the idea that
the inflammatory site, particularly the presence of inflammatory
macrophages, can influence the expression of MR and thereby
influence function and persistence of T cells.
It is important to bear in mind that tissue-specific responses
can be re-programed by the exposure of T cells to alternative envi-
ronments. For example, in a tumor model in which the site of
implantation led to CD8+ T cell priming in different LN, differ-
ent patterns of expression of integrins and selectin ligands were
acquired by dividing cells in different sites that were associated
with differential homing (71). Another study showed that CD4+
T cells primed in the gut-associated mesenteric LN by oral immu-
nization acquired a skin-homing phenotype when transferred to
recipients immunized subcutaneously (72). In addition to the
significant role of DC imprinting on the acquisition of tissue-
specific homing, DC trafficking itself has a substantial impact on
T cell migratory heterogeneity [reviewed in Ref. (73)]. In con-
clusion, the function and location of effector T cells is governed
by the expression of distinct MR combinations that are regu-
lated by the environment. The combination of cell types and
chemokines that are induced in response to inflammation can
dramatically alter the environment within the tissue, which can
significantly alter the MR phenotype and influence T cell migra-
tion. This suggests that phenotypes with respect to MR expression
can be dynamically modulated for therapeutic purposes at particu-
lar sites to maximize vaccine efficacy and protection from invading
pathogens.
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MR SIGNALING DIRECTS MOVEMENT OF T CELLS INTO AND
WITHIN PERIPHERAL TISSUES
MR-mediated localization of cells from blood into tissue is well-
studied. Once activated in SLO, T cells are released into the
circulation, a process that is regulated by the presence of high
concentrations of S1P, in the lymphatic vessels (29). Once in the
circulation, effector T cells are directed to sites of inflammation
by activated endothelium. Pro-inflammatory mediators includ-
ing TNF-α, IL-1, and IL-6 can rapidly activate endothelial cells
to upregulate expression of selectins and CD44 (5). The latter
binds to its ligand HA that is liberated as fragments from the
ECM in response to inflammation [reviewed in Ref. (74)]. These
molecules can be functionally redundant with respect to migra-
tion and individually regulate T cell encounters with the luminal
surface of the vasculature through engagement of PSGL-1 or E-
Selectin ligand. Chemokines, presented or secreted by endothelial
cells as a consequence of the innate response, induce signaling via G
protein-coupled receptors that upregulate the adhesiveness of inte-
grins for their counter receptors that include ICAM-1, VCAM-1,
and MadCAM-1 [reviewed in Ref. (5)].
Much less is known regarding the mechanisms that are engaged
to mediate movement of cells within tissues. Upon extravasation, T
cells must traverse the basement membrane, which is achieved by
activation of matrix metalloproteases (MMPs). MMPs facilitate
migration into and within the tissue interstitium by proteolytic
degradation of ECM components. T cells predominantly produce
the gelatinases MMP2 and MMP9 that cleave type IV collagen (75).
We and others find that different T cell subsets express different
amounts of MMP2 or MMP9 in vitro [Baaten, unpublished obser-
vation, (76,77)]. It is unclear what induces activity in vivo and what
causes their differential induction in these subsets, but the numer-
ous cell–cell contact-dependent interactions via selectins, CCRs,
and integrins during the extravasation process could impact MMP
expression and/or activity. Initial interactions with the endothelial
layer could upregulate MMP expression in T cells during transmi-
gration (78–81). MMP2 and MMP9 production in T cells can be
induced by ligation of integrins (αLβ2,α4β1,α5β1,αVβ1) following
interaction with the endothelial layer (e.g., ICAM, VCAM) or con-
stituents of the basement membrane (e.g., fibronectin) (80–86).
Depending on the type of integrin, differential MMP expression
can be induced in T cells (80). Thus, MR heterogeneity could
impact T cell motility by regulating MMP activity. In addition,
integrins are able to bind MMP2 and MMP9, which has been pro-
posed to target catalytic activity to specific substrates within the
pericellular space and assist cellular invasion (87, 88). However,
the in vivo function of gelatinase activity for basement membrane
degradation remains controversial and proteolytic cleavage of both
ECM and non-ECM substrates can regulate migration and motil-
ity through other mechanisms (89). For example, chemotactic
factors or MR expression could be altered by MMP-mediated pro-
teolysis (90) thereby modulating T cell migration. More studies are
required to identify how the molecular events that regulate rolling
and tethering affect the phenotype and function of migrating T
cells during transmigration.
To achieve directed migration, T cells undergo cytoskeletal
rearrangements that allow for the formation of a polarized shape
with a leading edge and a uropod that remains in contact with
the ECM (91, 92). This process requires multiple signaling events
that translate signals from membrane proteins into cell movement.
Actin polymerization, regulated by members of the Rho GTPase
family (93), controls forward movement of the cell at the leading
edge where CCRs (94), integrins, and the TCR are located. The
cell organelles, microtubule organizing center, and Golgi appara-
tus, as well as most MR, including PSGL-1, CD44, CD62L, and
ICAM-1, become localized in the uropod. These receptors con-
tribute to the signaling processes that regulate cell migration by
binding ezrin and moesin, which anchor MR to the actin cytoskele-
ton and support the formation of clusters of MR. ERM proteins
are activated through PI3K signaling to associate with the cyto-
plasmic domains of MR in the uropod, where they can serve as
adaptor proteins for signal transduction. There can be consider-
able crosstalk between MR in response to signaling. For example,
ligation of either PSGL-1 or CD44 can be associated with PI3K
activation. Functional PSGL-1 also requires recruitment of ERM
proteins to transmit signals necessary for adhesion (95). The acti-
vation status of ERM proteins is positively regulated by RhoA (93)
that signals through the Rho-associated kinase, ROCK, which has
critical roles in cell division and cell survival (96). Rho activation
is associated contraction of the uropod that enables the forward
movement of the cells (97).
The signaling pathways engaged by MR to mediate cell move-
ment can profoundly modulate effector T cell responses and fitness
for proliferation and survival. During T cell movement within tis-
sues, signaling pathways continue to be dynamically regulated by
engagement of the ECM via CD44 and integrins. For example, in
a tumor model, Cd44-deficient CD8+ effector T cells could not
maintain polarity and as a consequence had impaired cytotoxic
activity (98). Recently, the integrin αV was demonstrated to be
involved in context-dependent motility of Th1 cells in inflamed
skin, and its expression was crucial for pathogen clearance (99).
During migration within tissues T cells interact with other migrat-
ing and non-migrating cells including DC and tissue macrophages,
which can present antigens and produce cytokines to enhance the
effector T cell response. For instance, after influenza virus infec-
tion, DC elicit both cytotoxic activity and cytokine production
that was dependent upon co-stimulation via CD80 and CD86,
whereas engagement of epithelial cells that lack these receptors
selectively stimulated cytotoxicity (100), revealing that effector
cells can display heterogeneity depending on contextual cues.
ROLE OF LOCATION AND MR SIGNALING ON THE EFFECTOR
TO MEMORY T CELL TRANSITION
The hallmark of immunological memory is a quicker and more
effective response upon re-encountering a pathogen. Migratory
capacity can be intimately associated with effector function of
responding cells at sites of inflammation that have the potential
to become memory cells. MR contribute significantly to the func-
tionality of memory T cells by enabling migration for surveillance,
motility for in situ positioning, and signal interpretation from the
ECM that enable cell survival. The timing of migration of naïve T
cells into an inflamed LN can impact the formation of memory.
Naïve T cells that enter LN later during the immune response are
more likely to become central memory T cells (101, 102). These
T cells receive less stimulation and consequently are less likely to
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adopt the migratory phenotype characterized by loss of CD62L
and CCR7, and upregulation of integrins and PSGL-1. Strength of
signaling also impacts the PI3K/Akt-mTOR pathway (see above)
that can also influence the development of memory. Inhibition of
this pathway limits differentiation of effector CD8+ T cells and
results in greater generation of central memory CD8+ T cells dur-
ing acute lymphocytic choriomeningitis virus (LCMV) infection
(23). Memory T cells that preserve expression of CD62L and CCR7
maintain the migration patterns of naïve cells through SLO, allow-
ing them to maximize the chance of finding antigen-specific DC
early during a re-infection. These T cells also maintain expression
of IL-2, a key cytokine for optimal memory cell responses [Swain,
unpublished observations, (103, 104)].
Although the majority of effector T cells responding to
pathogens in non-lymphoid tissues lack naïve T cell MR expres-
sion, CCR7 distinguishes T cells with the capacity to egress from
non-lymphoid organs, such as the skin and lung (105, 106). While
most effector cells in the lung die by apoptosis, some responding T
cells can undergo regulated egress via the lymphatics and return to
the circulation by engagement of the CCR7 ligand CCL21, which
is expressed on lymphatic endothelium. Since effector CD4+ T
cells responding to lung inflammation can be partitioned into
subsets by expression of CCR7 (107), it is possible that these rep-
resent functionally distinct effectors with those capable of egress
having a greater potential for survival and effector memory for-
mation in SLO. Interestingly, the absence of CCR7 is associated
with effector cell accumulation in the lung in allergic inflamma-
tion, suggesting that CCR7-regulated egress from the lungs may be
an important factor in terminating the effector response (108). In
addition, S1P may contribute to the regulation of egress from non-
lymphoid tissues (109). However, some effector T cells express
CD103 and are programed to persist in non-lymphoid sites. These
effector memory T cells are known as tissue resident memory cells
that are thought to provide site-specific protection against repeat
infections (110). Their localization and persistence is mediated by
MR to facilitate the accelerated response to re-encounter with an
antigen.
Although MR expression predicts differences in migration of
memory T cells to SLO and peripheral tissues, it is now becoming
clear that this can have important functional consequences. In the
skin, the anatomical localization and migration pattern of CD4+
and CD8+ memory T cells are substantially different following
epicutaneous infection with herpes simplex virus as a result of
distinct migratory programing in these two subpopulations (111).
Whereas CD103+ CD8+memory T cells remained in the epider-
mis as tissue resident memory cells, CD4+ effector memory T
cells resided in the dermis, but were highly mobile and able to
recirculate due to expression of E/P-selectin ligands. Whether this
migration-linked T cell subset specialization is further impacted
by T cell heterogeneity within the subsets is unknown. Neverthe-
less, signals received from the ECM via MR in situ can modulate
the effector program to increase the potential for surviving the
contraction phase of an immune response to enable transition
to memory. For example, CD8+ and CD4+ T cells infiltrating
the lung can differentially express α1β1 and α2β1 (CD49b, VLA-
2), respectively (112). As a result, the different subsets localize to
different areas within the lungs: CD8+ T cells that preferentially
express α1β1 locate near the basement membranes of either the
airways or blood vessels, whereas α2β1 CD4+ T cells primarily
localize within the interstitial spaces. After influenza virus infec-
tion,α1β1-binding of collagen allows memory T cells to persist and
function in the lungs (59, 113, 114). Similarly, signaling via CD44 is
necessary for the survival of Th1 effector cells in lungs and the tran-
sition to memory (115). We and others find that acquisition of HA
binding capacity by CD8+ T cells distinguishes effector cells with
a greater potential to form memory cells [Bradley, unpublished
observations, (116)].
It is becoming increasingly appreciated that microanatomical
location can be critical in determining the signals that T cells
receive during activation (86), but perhaps also during home-
ostasis and transition to memory. For example, T cells that are
in proximity to the lymphatic vessels in the LN have ready access
to antigens and pro-inflammatory cytokines that drain from sites
of infection (117). In some viral and bacterial infections, notably
systemic infections with LCMV (118) or Listeria monocytogenes
(119), potent, but short-lived CD8+ effector T cells are distin-
guished by high expression of KLRG1 and low levels of IL-7Rα,
whereas effectors with the reciprocal phenotype are better able
to form memory cells. During acute infection with LCMV, short-
lived effector CD8+ T cells are localized in the red pulp, whereas
memory precursors preferentially locate to the white pulp in con-
tact with stromal cells that produce IL-7 (120). During chronic
LCMV infection, which leads to T cell exhaustion with sustained
expression of the inhibitory receptor, programed death-1 (PD-
1), both CD4+ and CD8+ effector T cells locate in the red pulp
where their motility is impaired by PD-1 engagement of PD-L1
on macrophages and DC (121). However, in acute infections PD-1
plays a role in preventing terminal Th1 and CD8+ effector cell
differentiation following pathogen clearance (122), highlighting
that the integration of positive and negative signals is crucial for
both the development of functional effector cells and memory.
These examples underscore that a coordinated interplay of signal-
ing via MR and the cytoskeleton is integral to T cell responses and
survival within tissues and demonstrate the complexity and differ-
ences of CD4+ and CD8+ memory T cell responses and suggest
that interactions with the ECM at the site of infection could have a
significant impact on T cell function. By extension it is likely that
MR signals play roles in the micro-location of effector and memory
subsets that enable them to receive optimum homeostatic signals.
CONCLUSION
The ability of T cells to move around the body is crucial for
their effector function and immunity to infection with pathogens.
CD4+ and CD8+ T cells are heterogeneous and subsets have been
defined based on the expression of CCRs, selectins, and integrins
that are able to engage inflamed endothelium, the ECM, and cells
of the innate immune system. For effector T cells that relocate to
sites of inflammation, considerable plasticity in their responses can
occur during the priming process with DC that imparts a tissue-
specific MR phenotype to ensure efficient homing of activated T
cells to the correct tissue. There are many mechanisms that con-
tribute to control of T cell migration, motility, and egress within
tissues and the coordinated interplay of these signals are only now
becoming appreciated as crucial regulators of T cell function. MR
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are able to provide important contextual information from the
ECM that allow for distinct transcriptional profiles that dictates
not only cell polarity and interstitial motility, but also effector
function, cell survival, and transition to, and maintenance of
memory. Thus, MR heterogeneity has a direct impact on T cell
immunity and protection from invading pathogens. The identi-
fication of additional distinct tissue profiles and the molecular
mechanisms that control them have direct therapeutic relevance.
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